nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—melanoma	0.459	0.72	CbGbCtD
Furosemide—ALB—melanoma	0.135	1	CbGaD
Furosemide—SLC22A5—Dactinomycin—melanoma	0.0839	0.132	CbGbCtD
Furosemide—ALB—Vemurafenib—melanoma	0.0612	0.096	CbGbCtD
Furosemide—ABCC2—Docetaxel—melanoma	0.0337	0.0529	CbGbCtD
Furosemide—CA6—ear—melanoma	0.00659	0.137	CbGeAlD
Furosemide—SLC12A1—appendage—melanoma	0.00452	0.0942	CbGeAlD
Furosemide—SLC22A8—optic choroid—melanoma	0.00386	0.0805	CbGeAlD
Furosemide—CA6—hair follicle—melanoma	0.00348	0.0724	CbGeAlD
Furosemide—SLCO2A1—neck—melanoma	0.00166	0.0346	CbGeAlD
Furosemide—PGD—neck—melanoma	0.00148	0.0309	CbGeAlD
Furosemide—SLCO2A1—eye—melanoma	0.00124	0.0258	CbGeAlD
Furosemide—CA2—hair follicle—melanoma	0.0012	0.0249	CbGeAlD
Furosemide—CA12—eye—melanoma	0.00116	0.0242	CbGeAlD
Furosemide—PGD—eye—melanoma	0.0011	0.023	CbGeAlD
Furosemide—PGD—retina—melanoma	0.00109	0.0228	CbGeAlD
Furosemide—SLCO2A1—skin of body—melanoma	0.00108	0.0224	CbGeAlD
Furosemide—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.000988	0.00923	CcSEcCtD
Furosemide—CA6—head—melanoma	0.000985	0.0205	CbGeAlD
Furosemide—SLCO2A1—mammalian vulva—melanoma	0.000981	0.0204	CbGeAlD
Furosemide—Injection site pain—Carmustine—melanoma	0.000979	0.00915	CcSEcCtD
Furosemide—CA4—neck—melanoma	0.000968	0.0202	CbGeAlD
Furosemide—PGD—skin of body—melanoma	0.000959	0.02	CbGeAlD
Furosemide—Eosinophilia—Vemurafenib—melanoma	0.000939	0.00877	CcSEcCtD
Furosemide—Hypocalcaemia—Dactinomycin—melanoma	0.000933	0.00872	CcSEcCtD
Furosemide—CA1—eye—melanoma	0.000922	0.0192	CbGeAlD
Furosemide—Disturbance in attention—Temozolomide—melanoma	0.000891	0.00833	CcSEcCtD
Furosemide—PGD—mammalian vulva—melanoma	0.000874	0.0182	CbGeAlD
Furosemide—Photosensitivity reaction—Vemurafenib—melanoma	0.000865	0.00809	CcSEcCtD
Furosemide—Drug interaction—Carmustine—melanoma	0.000861	0.00805	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000838	0.00783	CcSEcCtD
Furosemide—Eruption—Docetaxel—melanoma	0.000835	0.0078	CcSEcCtD
Furosemide—CA5B—mammalian vulva—melanoma	0.000828	0.0173	CbGeAlD
Furosemide—Bladder pain—Bleomycin—melanoma	0.000828	0.00774	CcSEcCtD
Furosemide—Hearing impaired—Temozolomide—melanoma	0.000811	0.00758	CcSEcCtD
Furosemide—CA2—neck—melanoma	0.000803	0.0167	CbGeAlD
Furosemide—Aplastic anaemia—Dactinomycin—melanoma	0.000802	0.00749	CcSEcCtD
Furosemide—SLC22A8—eye—melanoma	0.000777	0.0162	CbGeAlD
Furosemide—SLC12A1—head—melanoma	0.00076	0.0158	CbGeAlD
Furosemide—Aplastic anaemia—Temozolomide—melanoma	0.000725	0.00678	CcSEcCtD
Furosemide—Erythema multiforme—Vemurafenib—melanoma	0.000717	0.00671	CcSEcCtD
Furosemide—Eye disorder—Vemurafenib—melanoma	0.000709	0.00663	CcSEcCtD
Furosemide—SLCO2A1—head—melanoma	0.000702	0.0146	CbGeAlD
Furosemide—Mental disability—Carmustine—melanoma	0.000693	0.00648	CcSEcCtD
Furosemide—Angiopathy—Vemurafenib—melanoma	0.000688	0.00644	CcSEcCtD
Furosemide—Mental disability—Temozolomide—melanoma	0.00067	0.00626	CcSEcCtD
Furosemide—Thrombophlebitis—Carmustine—melanoma	0.00067	0.00626	CcSEcCtD
Furosemide—Diabetes mellitus—Carmustine—melanoma	0.000667	0.00623	CcSEcCtD
Furosemide—Malnutrition—Vemurafenib—melanoma	0.000661	0.00618	CcSEcCtD
Furosemide—Erythema—Vemurafenib—melanoma	0.000661	0.00618	CcSEcCtD
Furosemide—CA12—head—melanoma	0.00066	0.0138	CbGeAlD
Furosemide—Swelling—Carmustine—melanoma	0.000658	0.00615	CcSEcCtD
Furosemide—Thrombophlebitis—Temozolomide—melanoma	0.000648	0.00605	CcSEcCtD
Furosemide—Dysgeusia—Vemurafenib—melanoma	0.000647	0.00605	CcSEcCtD
Furosemide—Lethargy—Dactinomycin—melanoma	0.000632	0.00591	CcSEcCtD
Furosemide—Deafness—Temozolomide—melanoma	0.000627	0.00586	CcSEcCtD
Furosemide—Vascular purpura—Temozolomide—melanoma	0.000627	0.00586	CcSEcCtD
Furosemide—PGD—head—melanoma	0.000625	0.013	CbGeAlD
Furosemide—CA2—eye—melanoma	0.000597	0.0124	CbGeAlD
Furosemide—Dermatitis exfoliative—Temozolomide—melanoma	0.000594	0.00555	CcSEcCtD
Furosemide—CA5B—head—melanoma	0.000592	0.0123	CbGeAlD
Furosemide—CA2—retina—melanoma	0.000592	0.0123	CbGeAlD
Furosemide—Thirst—Temozolomide—melanoma	0.000589	0.00551	CcSEcCtD
Furosemide—Hyponatraemia—Carmustine—melanoma	0.000582	0.00544	CcSEcCtD
Furosemide—SLC22A5—retina—melanoma	0.000582	0.0121	CbGeAlD
Furosemide—Purpura—Temozolomide—melanoma	0.000582	0.00544	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000559	0.00522	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000558	0.00522	CcSEcCtD
Furosemide—Drug interaction—Docetaxel—melanoma	0.000554	0.00518	CcSEcCtD
Furosemide—Hearing impaired—Docetaxel—melanoma	0.00054	0.00504	CcSEcCtD
Furosemide—Anaphylactic shock—Vemurafenib—melanoma	0.000539	0.00504	CcSEcCtD
Furosemide—Nervous system disorder—Vemurafenib—melanoma	0.000529	0.00494	CcSEcCtD
Furosemide—Hypokalaemia—Carmustine—melanoma	0.000528	0.00494	CcSEcCtD
Furosemide—Skin disorder—Vemurafenib—melanoma	0.000524	0.0049	CcSEcCtD
Furosemide—CA1—head—melanoma	0.000523	0.0109	CbGeAlD
Furosemide—Dehydration—Temozolomide—melanoma	0.000521	0.00487	CcSEcCtD
Furosemide—CA2—skin of body—melanoma	0.00052	0.0108	CbGeAlD
Furosemide—Muscular weakness—Carmustine—melanoma	0.000512	0.00478	CcSEcCtD
Furosemide—SLC22A5—skin of body—melanoma	0.000511	0.0107	CbGeAlD
Furosemide—Hypokalaemia—Temozolomide—melanoma	0.00051	0.00477	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000505	0.00472	CcSEcCtD
Furosemide—Hypotension—Vemurafenib—melanoma	0.000504	0.00471	CcSEcCtD
Furosemide—Muscular weakness—Temozolomide—melanoma	0.000494	0.00462	CcSEcCtD
Furosemide—SLCO2A1—lymph node—melanoma	0.000491	0.0102	CbGeAlD
Furosemide—Abdominal distension—Temozolomide—melanoma	0.000488	0.00456	CcSEcCtD
Furosemide—CA2—mammalian vulva—melanoma	0.000474	0.00988	CbGeAlD
Furosemide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000474	0.00443	CcSEcCtD
Furosemide—Decreased appetite—Vemurafenib—melanoma	0.000469	0.00438	CcSEcCtD
Furosemide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000465	0.00435	CcSEcCtD
Furosemide—Fatigue—Vemurafenib—melanoma	0.000465	0.00434	CcSEcCtD
Furosemide—Constipation—Vemurafenib—melanoma	0.000461	0.00431	CcSEcCtD
Furosemide—Lightheadedness—Docetaxel—melanoma	0.000459	0.0043	CcSEcCtD
Furosemide—Hyperglycaemia—Carmustine—melanoma	0.000452	0.00423	CcSEcCtD
Furosemide—Pollakiuria—Temozolomide—melanoma	0.000448	0.00418	CcSEcCtD
Furosemide—Agranulocytosis—Dactinomycin—melanoma	0.000446	0.00417	CcSEcCtD
Furosemide—Photosensitivity reaction—Temozolomide—melanoma	0.000442	0.00413	CcSEcCtD
Furosemide—SLC22A8—head—melanoma	0.000441	0.0092	CbGeAlD
Furosemide—Renal failure—Carmustine—melanoma	0.000439	0.00411	CcSEcCtD
Furosemide—PGD—lymph node—melanoma	0.000438	0.00913	CbGeAlD
Furosemide—Hyperglycaemia—Temozolomide—melanoma	0.000437	0.00409	CcSEcCtD
Furosemide—Thrombophlebitis—Docetaxel—melanoma	0.000431	0.00403	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000428	0.004	CcSEcCtD
Furosemide—Body temperature increased—Vemurafenib—melanoma	0.000426	0.00398	CcSEcCtD
Furosemide—Swelling—Docetaxel—melanoma	0.000423	0.00395	CcSEcCtD
Furosemide—Deafness—Docetaxel—melanoma	0.000417	0.0039	CcSEcCtD
Furosemide—CA5B—lymph node—melanoma	0.000415	0.00865	CbGeAlD
Furosemide—CA4—head—melanoma	0.000409	0.00852	CbGeAlD
Furosemide—Hepatobiliary disease—Temozolomide—melanoma	0.000409	0.00382	CcSEcCtD
Furosemide—Erythema multiforme—Dactinomycin—melanoma	0.000405	0.00379	CcSEcCtD
Furosemide—Erythema—Bleomycin—melanoma	0.0004	0.00374	CcSEcCtD
Furosemide—Hypersensitivity—Vemurafenib—melanoma	0.000397	0.00371	CcSEcCtD
Furosemide—Dermatitis bullous—Docetaxel—melanoma	0.00039	0.00365	CcSEcCtD
Furosemide—Asthenia—Vemurafenib—melanoma	0.000387	0.00362	CcSEcCtD
Furosemide—Visual impairment—Carmustine—melanoma	0.000387	0.00362	CcSEcCtD
Furosemide—Urinary tract disorder—Temozolomide—melanoma	0.000383	0.00358	CcSEcCtD
Furosemide—Pruritus—Vemurafenib—melanoma	0.000381	0.00357	CcSEcCtD
Furosemide—Lethargy—Docetaxel—melanoma	0.00038	0.00356	CcSEcCtD
Furosemide—Urethral disorder—Temozolomide—melanoma	0.00038	0.00355	CcSEcCtD
Furosemide—Eye disorder—Carmustine—melanoma	0.000375	0.00351	CcSEcCtD
Furosemide—Hyponatraemia—Docetaxel—melanoma	0.000374	0.0035	CcSEcCtD
Furosemide—Visual impairment—Temozolomide—melanoma	0.000374	0.00349	CcSEcCtD
Furosemide—Erythema—Dactinomycin—melanoma	0.000373	0.00349	CcSEcCtD
Furosemide—Anaemia—Bleomycin—melanoma	0.00037	0.00346	CcSEcCtD
Furosemide—Diarrhoea—Vemurafenib—melanoma	0.000369	0.00345	CcSEcCtD
Furosemide—Erythema multiforme—Temozolomide—melanoma	0.000367	0.00343	CcSEcCtD
Furosemide—CA1—lymph node—melanoma	0.000366	0.00763	CbGeAlD
Furosemide—Eye disorder—Temozolomide—melanoma	0.000362	0.00339	CcSEcCtD
Furosemide—Tinnitus—Temozolomide—melanoma	0.000362	0.00338	CcSEcCtD
Furosemide—Arrhythmia—Carmustine—melanoma	0.000358	0.00335	CcSEcCtD
Furosemide—Leukopenia—Bleomycin—melanoma	0.000358	0.00335	CcSEcCtD
Furosemide—Dizziness—Vemurafenib—melanoma	0.000357	0.00333	CcSEcCtD
Furosemide—Angiopathy—Temozolomide—melanoma	0.000352	0.00329	CcSEcCtD
Furosemide—Immune system disorder—Temozolomide—melanoma	0.00035	0.00327	CcSEcCtD
Furosemide—Erythema—Carmustine—melanoma	0.000349	0.00327	CcSEcCtD
Furosemide—Malnutrition—Carmustine—melanoma	0.000349	0.00327	CcSEcCtD
Furosemide—Dehydration—Docetaxel—melanoma	0.000347	0.00324	CcSEcCtD
Furosemide—Anaemia—Dactinomycin—melanoma	0.000345	0.00322	CcSEcCtD
Furosemide—Vomiting—Vemurafenib—melanoma	0.000343	0.0032	CcSEcCtD
Furosemide—Orthostatic hypotension—Docetaxel—melanoma	0.00034	0.00318	CcSEcCtD
Furosemide—Rash—Vemurafenib—melanoma	0.00034	0.00318	CcSEcCtD
Furosemide—Dermatitis—Vemurafenib—melanoma	0.00034	0.00317	CcSEcCtD
Furosemide—CA2—head—melanoma	0.000339	0.00707	CbGeAlD
Furosemide—Headache—Vemurafenib—melanoma	0.000338	0.00316	CcSEcCtD
Furosemide—Erythema—Temozolomide—melanoma	0.000338	0.00316	CcSEcCtD
Furosemide—Malnutrition—Temozolomide—melanoma	0.000338	0.00316	CcSEcCtD
Furosemide—Cramp muscle—Docetaxel—melanoma	0.000336	0.00314	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000336	0.00314	CcSEcCtD
Furosemide—Leukopenia—Dactinomycin—melanoma	0.000334	0.00312	CcSEcCtD
Furosemide—Dysgeusia—Temozolomide—melanoma	0.000331	0.00309	CcSEcCtD
Furosemide—Confusional state—Bleomycin—melanoma	0.000329	0.00308	CcSEcCtD
Furosemide—Vision blurred—Carmustine—melanoma	0.000329	0.00308	CcSEcCtD
Furosemide—Anaphylactic shock—Bleomycin—melanoma	0.000327	0.00305	CcSEcCtD
Furosemide—Anaemia—Carmustine—melanoma	0.000323	0.00302	CcSEcCtD
Furosemide—ALB—lymph node—melanoma	0.000322	0.00671	CbGeAlD
Furosemide—Agitation—Carmustine—melanoma	0.000321	0.003	CcSEcCtD
Furosemide—Nausea—Vemurafenib—melanoma	0.00032	0.00299	CcSEcCtD
Furosemide—Thrombocytopenia—Bleomycin—melanoma	0.00032	0.00299	CcSEcCtD
Furosemide—Vision blurred—Temozolomide—melanoma	0.000318	0.00297	CcSEcCtD
Furosemide—Leukopenia—Carmustine—melanoma	0.000313	0.00292	CcSEcCtD
Furosemide—Anaemia—Temozolomide—melanoma	0.000312	0.00292	CcSEcCtD
Furosemide—Anorexia—Bleomycin—melanoma	0.000311	0.00291	CcSEcCtD
Furosemide—Agitation—Temozolomide—melanoma	0.00031	0.0029	CcSEcCtD
Furosemide—Hypotension—Bleomycin—melanoma	0.000305	0.00285	CcSEcCtD
Furosemide—Vertigo—Temozolomide—melanoma	0.000303	0.00284	CcSEcCtD
Furosemide—Leukopenia—Temozolomide—melanoma	0.000302	0.00282	CcSEcCtD
Furosemide—ABCC2—lymph node—melanoma	0.000302	0.00628	CbGeAlD
Furosemide—Thrombocytopenia—Dactinomycin—melanoma	0.000298	0.00279	CcSEcCtD
Furosemide—Paraesthesia—Bleomycin—melanoma	0.000293	0.00274	CcSEcCtD
Furosemide—Anorexia—Dactinomycin—melanoma	0.00029	0.00271	CcSEcCtD
Furosemide—Confusional state—Carmustine—melanoma	0.000287	0.00269	CcSEcCtD
Furosemide—CA4—lymph node—melanoma	0.000286	0.00597	CbGeAlD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000285	0.00267	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000285	0.00266	CcSEcCtD
Furosemide—Decreased appetite—Bleomycin—melanoma	0.000284	0.00265	CcSEcCtD
Furosemide—Renal failure—Docetaxel—melanoma	0.000282	0.00264	CcSEcCtD
Furosemide—Dry mouth—Temozolomide—melanoma	0.000281	0.00263	CcSEcCtD
Furosemide—Pain—Bleomycin—melanoma	0.000279	0.00261	CcSEcCtD
Furosemide—Thrombocytopenia—Carmustine—melanoma	0.000279	0.00261	CcSEcCtD
Furosemide—Confusional state—Temozolomide—melanoma	0.000278	0.0026	CcSEcCtD
Furosemide—Anaphylactic shock—Temozolomide—melanoma	0.000276	0.00258	CcSEcCtD
Furosemide—Anorexia—Carmustine—melanoma	0.000272	0.00254	CcSEcCtD
Furosemide—Hepatobiliary disease—Docetaxel—melanoma	0.000272	0.00254	CcSEcCtD
Furosemide—Nervous system disorder—Temozolomide—melanoma	0.00027	0.00253	CcSEcCtD
Furosemide—Thrombocytopenia—Temozolomide—melanoma	0.00027	0.00252	CcSEcCtD
Furosemide—Feeling abnormal—Bleomycin—melanoma	0.000269	0.00252	CcSEcCtD
Furosemide—Agranulocytosis—Docetaxel—melanoma	0.000268	0.00251	CcSEcCtD
Furosemide—Skin disorder—Temozolomide—melanoma	0.000268	0.0025	CcSEcCtD
Furosemide—Hypotension—Carmustine—melanoma	0.000266	0.00249	CcSEcCtD
Furosemide—Hyperhidrosis—Temozolomide—melanoma	0.000266	0.00249	CcSEcCtD
Furosemide—Decreased appetite—Dactinomycin—melanoma	0.000265	0.00248	CcSEcCtD
Furosemide—Fatigue—Dactinomycin—melanoma	0.000263	0.00246	CcSEcCtD
Furosemide—Anorexia—Temozolomide—melanoma	0.000263	0.00246	CcSEcCtD
Furosemide—Pain—Dactinomycin—melanoma	0.00026	0.00244	CcSEcCtD
Furosemide—Urticaria—Bleomycin—melanoma	0.000259	0.00243	CcSEcCtD
Furosemide—Body temperature increased—Bleomycin—melanoma	0.000258	0.00241	CcSEcCtD
Furosemide—Paraesthesia—Carmustine—melanoma	0.000256	0.00239	CcSEcCtD
Furosemide—Urinary tract disorder—Docetaxel—melanoma	0.000255	0.00238	CcSEcCtD
Furosemide—Somnolence—Carmustine—melanoma	0.000253	0.00237	CcSEcCtD
Furosemide—Urethral disorder—Docetaxel—melanoma	0.000253	0.00236	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—melanoma	0.000251	0.00235	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—melanoma	0.000249	0.00233	CcSEcCtD
Furosemide—Visual impairment—Docetaxel—melanoma	0.000249	0.00232	CcSEcCtD
Furosemide—Decreased appetite—Carmustine—melanoma	0.000248	0.00232	CcSEcCtD
Furosemide—Paraesthesia—Temozolomide—melanoma	0.000247	0.00231	CcSEcCtD
Furosemide—Gastrointestinal disorder—Carmustine—melanoma	0.000246	0.0023	CcSEcCtD
Furosemide—Somnolence—Temozolomide—melanoma	0.000245	0.00229	CcSEcCtD
Furosemide—Erythema multiforme—Docetaxel—melanoma	0.000244	0.00228	CcSEcCtD
Furosemide—Pain—Carmustine—melanoma	0.000244	0.00228	CcSEcCtD
Furosemide—Constipation—Carmustine—melanoma	0.000244	0.00228	CcSEcCtD
Furosemide—Eye disorder—Docetaxel—melanoma	0.000241	0.00225	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—melanoma	0.000241	0.00225	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—melanoma	0.000241	0.00225	CcSEcCtD
Furosemide—Hypersensitivity—Bleomycin—melanoma	0.000241	0.00225	CcSEcCtD
Furosemide—Decreased appetite—Temozolomide—melanoma	0.00024	0.00224	CcSEcCtD
Furosemide—Gastrointestinal disorder—Temozolomide—melanoma	0.000238	0.00222	CcSEcCtD
Furosemide—Fatigue—Temozolomide—melanoma	0.000238	0.00222	CcSEcCtD
Furosemide—CA2—lymph node—melanoma	0.000237	0.00495	CbGeAlD
Furosemide—Constipation—Temozolomide—melanoma	0.000236	0.0022	CcSEcCtD
Furosemide—Pain—Temozolomide—melanoma	0.000236	0.0022	CcSEcCtD
Furosemide—Feeling abnormal—Carmustine—melanoma	0.000235	0.0022	CcSEcCtD
Furosemide—Asthenia—Bleomycin—melanoma	0.000234	0.00219	CcSEcCtD
Furosemide—Angiopathy—Docetaxel—melanoma	0.000234	0.00219	CcSEcCtD
Furosemide—SLC22A5—lymph node—melanoma	0.000234	0.00487	CbGeAlD
Furosemide—Gastrointestinal pain—Carmustine—melanoma	0.000233	0.00218	CcSEcCtD
Furosemide—Immune system disorder—Docetaxel—melanoma	0.000233	0.00218	CcSEcCtD
Furosemide—Pruritus—Bleomycin—melanoma	0.000231	0.00216	CcSEcCtD
Furosemide—Arrhythmia—Docetaxel—melanoma	0.00023	0.00215	CcSEcCtD
Furosemide—Feeling abnormal—Temozolomide—melanoma	0.000227	0.00212	CcSEcCtD
Furosemide—Body temperature increased—Carmustine—melanoma	0.000225	0.00211	CcSEcCtD
Furosemide—Abdominal pain—Carmustine—melanoma	0.000225	0.00211	CcSEcCtD
Furosemide—Gastrointestinal pain—Temozolomide—melanoma	0.000225	0.00211	CcSEcCtD
Furosemide—Erythema—Docetaxel—melanoma	0.000225	0.0021	CcSEcCtD
Furosemide—Malnutrition—Docetaxel—melanoma	0.000225	0.0021	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—melanoma	0.000224	0.0021	CcSEcCtD
Furosemide—Dysgeusia—Docetaxel—melanoma	0.00022	0.00206	CcSEcCtD
Furosemide—Urticaria—Temozolomide—melanoma	0.000219	0.00205	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—melanoma	0.000219	0.00204	CcSEcCtD
Furosemide—Abdominal pain—Temozolomide—melanoma	0.000218	0.00204	CcSEcCtD
Furosemide—Body temperature increased—Temozolomide—melanoma	0.000218	0.00204	CcSEcCtD
Furosemide—Muscle spasms—Docetaxel—melanoma	0.000216	0.00202	CcSEcCtD
Furosemide—Hypersensitivity—Carmustine—melanoma	0.00021	0.00196	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—melanoma	0.000208	0.00195	CcSEcCtD
Furosemide—Vomiting—Bleomycin—melanoma	0.000208	0.00194	CcSEcCtD
Furosemide—Anaemia—Docetaxel—melanoma	0.000208	0.00194	CcSEcCtD
Furosemide—Rash—Bleomycin—melanoma	0.000206	0.00193	CcSEcCtD
Furosemide—Dermatitis—Bleomycin—melanoma	0.000206	0.00192	CcSEcCtD
Furosemide—Asthenia—Carmustine—melanoma	0.000205	0.00191	CcSEcCtD
Furosemide—Hypersensitivity—Temozolomide—melanoma	0.000203	0.0019	CcSEcCtD
Furosemide—Leukopenia—Docetaxel—melanoma	0.000201	0.00188	CcSEcCtD
Furosemide—Asthenia—Temozolomide—melanoma	0.000198	0.00185	CcSEcCtD
Furosemide—Diarrhoea—Carmustine—melanoma	0.000195	0.00182	CcSEcCtD
Furosemide—Pruritus—Temozolomide—melanoma	0.000195	0.00182	CcSEcCtD
Furosemide—Nausea—Bleomycin—melanoma	0.000194	0.00181	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—melanoma	0.000194	0.00181	CcSEcCtD
Furosemide—Rash—Dactinomycin—melanoma	0.000192	0.0018	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00019	0.00177	CcSEcCtD
Furosemide—Dizziness—Carmustine—melanoma	0.000189	0.00176	CcSEcCtD
Furosemide—Diarrhoea—Temozolomide—melanoma	0.000189	0.00176	CcSEcCtD
Furosemide—Dry mouth—Docetaxel—melanoma	0.000187	0.00175	CcSEcCtD
Furosemide—Confusional state—Docetaxel—melanoma	0.000185	0.00173	CcSEcCtD
Furosemide—Anaphylactic shock—Docetaxel—melanoma	0.000183	0.00171	CcSEcCtD
Furosemide—Dizziness—Temozolomide—melanoma	0.000182	0.0017	CcSEcCtD
Furosemide—Vomiting—Carmustine—melanoma	0.000181	0.00169	CcSEcCtD
Furosemide—Nausea—Dactinomycin—melanoma	0.000181	0.00169	CcSEcCtD
Furosemide—Shock—Docetaxel—melanoma	0.00018	0.00169	CcSEcCtD
Furosemide—Rash—Carmustine—melanoma	0.00018	0.00168	CcSEcCtD
Furosemide—Nervous system disorder—Docetaxel—melanoma	0.00018	0.00168	CcSEcCtD
Furosemide—Dermatitis—Carmustine—melanoma	0.00018	0.00168	CcSEcCtD
Furosemide—Thrombocytopenia—Docetaxel—melanoma	0.000179	0.00168	CcSEcCtD
Furosemide—Headache—Carmustine—melanoma	0.000179	0.00167	CcSEcCtD
Furosemide—Skin disorder—Docetaxel—melanoma	0.000178	0.00166	CcSEcCtD
Furosemide—Vomiting—Temozolomide—melanoma	0.000175	0.00164	CcSEcCtD
Furosemide—Anorexia—Docetaxel—melanoma	0.000175	0.00163	CcSEcCtD
Furosemide—Rash—Temozolomide—melanoma	0.000174	0.00162	CcSEcCtD
Furosemide—Dermatitis—Temozolomide—melanoma	0.000174	0.00162	CcSEcCtD
Furosemide—Headache—Temozolomide—melanoma	0.000173	0.00161	CcSEcCtD
Furosemide—Hypotension—Docetaxel—melanoma	0.000171	0.0016	CcSEcCtD
Furosemide—Nausea—Carmustine—melanoma	0.000169	0.00158	CcSEcCtD
Furosemide—Paraesthesia—Docetaxel—melanoma	0.000165	0.00154	CcSEcCtD
Furosemide—Nausea—Temozolomide—melanoma	0.000164	0.00153	CcSEcCtD
Furosemide—Somnolence—Docetaxel—melanoma	0.000163	0.00152	CcSEcCtD
Furosemide—Decreased appetite—Docetaxel—melanoma	0.000159	0.00149	CcSEcCtD
Furosemide—Gastrointestinal disorder—Docetaxel—melanoma	0.000158	0.00148	CcSEcCtD
Furosemide—Fatigue—Docetaxel—melanoma	0.000158	0.00148	CcSEcCtD
Furosemide—Pain—Docetaxel—melanoma	0.000157	0.00146	CcSEcCtD
Furosemide—Constipation—Docetaxel—melanoma	0.000157	0.00146	CcSEcCtD
Furosemide—Feeling abnormal—Docetaxel—melanoma	0.000151	0.00141	CcSEcCtD
Furosemide—Gastrointestinal pain—Docetaxel—melanoma	0.00015	0.0014	CcSEcCtD
Furosemide—Body temperature increased—Docetaxel—melanoma	0.000145	0.00135	CcSEcCtD
Furosemide—Abdominal pain—Docetaxel—melanoma	0.000145	0.00135	CcSEcCtD
Furosemide—Hypersensitivity—Docetaxel—melanoma	0.000135	0.00126	CcSEcCtD
Furosemide—Asthenia—Docetaxel—melanoma	0.000131	0.00123	CcSEcCtD
Furosemide—Pruritus—Docetaxel—melanoma	0.00013	0.00121	CcSEcCtD
Furosemide—Diarrhoea—Docetaxel—melanoma	0.000125	0.00117	CcSEcCtD
Furosemide—Dizziness—Docetaxel—melanoma	0.000121	0.00113	CcSEcCtD
Furosemide—Vomiting—Docetaxel—melanoma	0.000116	0.00109	CcSEcCtD
Furosemide—Rash—Docetaxel—melanoma	0.000116	0.00108	CcSEcCtD
Furosemide—Dermatitis—Docetaxel—melanoma	0.000115	0.00108	CcSEcCtD
Furosemide—Headache—Docetaxel—melanoma	0.000115	0.00107	CcSEcCtD
Furosemide—Nausea—Docetaxel—melanoma	0.000109	0.00102	CcSEcCtD
Furosemide—CA14—Metabolism—PIK3CG—melanoma	2.35e-05	0.000323	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAC2—melanoma	2.35e-05	0.000322	CbGpPWpGaD
Furosemide—PGD—Disease—MAP2K1—melanoma	2.33e-05	0.000321	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC5A5—melanoma	2.32e-05	0.000319	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CD—melanoma	2.32e-05	0.000319	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFC—melanoma	2.31e-05	0.000317	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CG—melanoma	2.29e-05	0.000315	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CG—melanoma	2.29e-05	0.000315	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPARG—melanoma	2.27e-05	0.000311	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	2.27e-05	0.000311	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—melanoma	2.26e-05	0.000311	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAC1—melanoma	2.25e-05	0.00031	CbGpPWpGaD
Furosemide—CA9—Metabolism—GNAQ—melanoma	2.24e-05	0.000308	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD44—melanoma	2.24e-05	0.000308	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—melanoma	2.23e-05	0.000306	CbGpPWpGaD
Furosemide—ALB—Metabolism—HS3ST5—melanoma	2.22e-05	0.000305	CbGpPWpGaD
Furosemide—PGD—Disease—FGF2—melanoma	2.22e-05	0.000305	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPARG—melanoma	2.21e-05	0.000304	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPARG—melanoma	2.21e-05	0.000304	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CG—melanoma	2.21e-05	0.000303	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	2.2e-05	0.000302	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—melanoma	2.19e-05	0.000301	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—melanoma	2.19e-05	0.000301	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1B1—melanoma	2.15e-05	0.000295	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CG—melanoma	2.14e-05	0.000294	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CG—melanoma	2.14e-05	0.000294	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—melanoma	2.13e-05	0.000293	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—melanoma	2.1e-05	0.000289	CbGpPWpGaD
Furosemide—PGD—Disease—MDM2—melanoma	2.08e-05	0.000285	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—melanoma	2.07e-05	0.000284	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CD—melanoma	2.07e-05	0.000284	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—melanoma	2.06e-05	0.000283	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—melanoma	2.06e-05	0.000283	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—melanoma	2.05e-05	0.000281	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—melanoma	2.04e-05	0.00028	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—melanoma	2.04e-05	0.00028	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2R—melanoma	2.03e-05	0.000279	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SPARC—melanoma	2.03e-05	0.000279	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CB—melanoma	2.02e-05	0.000278	CbGpPWpGaD
Furosemide—PGD—Disease—CD4—melanoma	2.02e-05	0.000277	CbGpPWpGaD
Furosemide—CA4—Metabolism—PRKCA—melanoma	2.02e-05	0.000277	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—melanoma	2.01e-05	0.000277	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CD—melanoma	2.01e-05	0.000276	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CD—melanoma	2.01e-05	0.000276	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—melanoma	2e-05	0.000275	CbGpPWpGaD
Furosemide—CA4—Metabolism—ERCC2—melanoma	2e-05	0.000275	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	1.99e-05	0.000273	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—melanoma	1.99e-05	0.000273	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—melanoma	1.99e-05	0.000273	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—melanoma	1.98e-05	0.000272	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CD—melanoma	1.94e-05	0.000267	CbGpPWpGaD
Furosemide—CA2—Metabolism—PRKCA—melanoma	1.93e-05	0.000266	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—melanoma	1.92e-05	0.000263	CbGpPWpGaD
Furosemide—CA2—Metabolism—ERCC2—melanoma	1.92e-05	0.000263	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—melanoma	1.91e-05	0.000263	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	1.9e-05	0.000262	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HSPA5—melanoma	1.9e-05	0.000261	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1B—melanoma	1.9e-05	0.000261	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	1.88e-05	0.000259	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	1.88e-05	0.000258	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CD—melanoma	1.88e-05	0.000258	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CD—melanoma	1.88e-05	0.000258	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNA11—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GAB2—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Furosemide—CA1—Metabolism—PRKCA—melanoma	1.85e-05	0.000255	CbGpPWpGaD
Furosemide—CA1—Metabolism—ERCC2—melanoma	1.84e-05	0.000252	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CB—melanoma	1.8e-05	0.000247	CbGpPWpGaD
Furosemide—PGD—Disease—CTNNB1—melanoma	1.79e-05	0.000246	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.79e-05	0.000246	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—melanoma	1.78e-05	0.000245	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—melanoma	1.77e-05	0.000243	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CB—melanoma	1.75e-05	0.000241	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CB—melanoma	1.75e-05	0.000241	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1A—melanoma	1.75e-05	0.00024	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—melanoma	1.75e-05	0.00024	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HDAC2—melanoma	1.74e-05	0.00024	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CD—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNAQ—melanoma	1.72e-05	0.000237	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGA4—melanoma	1.72e-05	0.000237	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD44—melanoma	1.72e-05	0.000237	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—melanoma	1.72e-05	0.000236	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNB1—melanoma	1.71e-05	0.000235	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	1.7e-05	0.000233	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CB—melanoma	1.69e-05	0.000233	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCB4—melanoma	1.68e-05	0.000231	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—melanoma	1.68e-05	0.00023	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	1.67e-05	0.00023	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA1—melanoma	1.67e-05	0.000229	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	1.65e-05	0.000227	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—melanoma	1.65e-05	0.000226	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—melanoma	1.64e-05	0.000225	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—melanoma	1.64e-05	0.000225	CbGpPWpGaD
Furosemide—CA9—Metabolism—PRKCA—melanoma	1.63e-05	0.000224	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—melanoma	1.62e-05	0.000223	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—melanoma	1.62e-05	0.000223	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SYK—melanoma	1.62e-05	0.000223	CbGpPWpGaD
Furosemide—CA9—Metabolism—ERCC2—melanoma	1.62e-05	0.000222	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGAV—melanoma	1.59e-05	0.000219	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT3—melanoma	1.59e-05	0.000219	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC6A11—melanoma	1.58e-05	0.000217	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIP4K2A—melanoma	1.58e-05	0.000217	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—melanoma	1.58e-05	0.000217	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—melanoma	1.56e-05	0.000215	CbGpPWpGaD
Furosemide—PGD—Disease—NRAS—melanoma	1.56e-05	0.000214	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—melanoma	1.56e-05	0.000214	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA2—melanoma	1.55e-05	0.000214	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	1.55e-05	0.000212	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTAP—melanoma	1.54e-05	0.000212	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—melanoma	1.52e-05	0.000209	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—melanoma	1.51e-05	0.000208	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.51e-05	0.000207	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—melanoma	1.5e-05	0.000207	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK3—melanoma	1.49e-05	0.000205	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—melanoma	1.46e-05	0.000201	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—melanoma	1.46e-05	0.000201	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—melanoma	1.45e-05	0.000199	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—melanoma	1.45e-05	0.000199	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGB1—melanoma	1.45e-05	0.000199	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK1—melanoma	1.42e-05	0.000195	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—melanoma	1.42e-05	0.000195	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	1.42e-05	0.000195	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—melanoma	1.42e-05	0.000194	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—melanoma	1.42e-05	0.000194	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—melanoma	1.4e-05	0.000192	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—melanoma	1.39e-05	0.000191	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	1.37e-05	0.000189	CbGpPWpGaD
Furosemide—ALB—Metabolism—PHGDH—melanoma	1.37e-05	0.000189	CbGpPWpGaD
Furosemide—ALB—Metabolism—LUM—melanoma	1.37e-05	0.000189	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—melanoma	1.37e-05	0.000188	CbGpPWpGaD
Furosemide—ALB—Metabolism—HPSE—melanoma	1.35e-05	0.000185	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—melanoma	1.34e-05	0.000184	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	1.34e-05	0.000184	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—melanoma	1.33e-05	0.000183	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HGF—melanoma	1.32e-05	0.000182	CbGpPWpGaD
Furosemide—ALB—Metabolism—CUBN—melanoma	1.32e-05	0.000182	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CSF2—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Furosemide—ALB—Metabolism—BSG—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Furosemide—ALB—Metabolism—CSPG4—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDHD—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—melanoma	1.26e-05	0.000173	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGB3—melanoma	1.25e-05	0.000172	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCA—melanoma	1.25e-05	0.000172	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPAM—melanoma	1.24e-05	0.00017	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—melanoma	1.23e-05	0.000169	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—melanoma	1.23e-05	0.000169	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—melanoma	1.21e-05	0.000166	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—melanoma	1.2e-05	0.000165	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.18e-05	0.000162	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAC1—melanoma	1.16e-05	0.00016	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—melanoma	1.16e-05	0.000159	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—melanoma	1.15e-05	0.000158	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—melanoma	1.14e-05	0.000157	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.14e-05	0.000156	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—melanoma	1.12e-05	0.000154	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—melanoma	1.12e-05	0.000154	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—melanoma	1.11e-05	0.000153	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—melanoma	1.11e-05	0.000152	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CDK2—melanoma	1.1e-05	0.000152	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—melanoma	1.1e-05	0.000151	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—melanoma	1.1e-05	0.000151	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.08e-05	0.000148	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—melanoma	1.07e-05	0.000147	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—melanoma	1.07e-05	0.000147	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G6—melanoma	1.05e-05	0.000144	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—melanoma	1.05e-05	0.000144	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—melanoma	1.03e-05	0.000142	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FN1—melanoma	1.03e-05	0.000141	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.03e-05	0.000141	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—melanoma	1.01e-05	0.000139	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—melanoma	1.01e-05	0.000138	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—melanoma	1e-05	0.000138	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—melanoma	9.99e-06	0.000137	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—melanoma	9.99e-06	0.000137	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—melanoma	9.82e-06	0.000135	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—melanoma	9.78e-06	0.000134	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EGF—melanoma	9.7e-06	0.000133	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—melanoma	9.69e-06	0.000133	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—melanoma	9.61e-06	0.000132	CbGpPWpGaD
Furosemide—ALB—Metabolism—VCAN—melanoma	9.44e-06	0.00013	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—melanoma	9.25e-06	0.000127	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—melanoma	8.99e-06	0.000123	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—melanoma	8.97e-06	0.000123	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.94e-06	0.000123	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	8.9e-06	0.000122	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—melanoma	8.74e-06	0.00012	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—melanoma	8.74e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—melanoma	8.63e-06	0.000119	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.63e-06	0.000118	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—melanoma	8.45e-06	0.000116	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—melanoma	8.43e-06	0.000116	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—melanoma	8.16e-06	0.000112	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—melanoma	8.16e-06	0.000112	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP17A1—melanoma	7.97e-06	0.000109	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.86e-06	0.000108	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—melanoma	7.56e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNA11—melanoma	7.52e-06	0.000103	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—melanoma	7.52e-06	0.000103	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—melanoma	7.38e-06	0.000101	CbGpPWpGaD
Furosemide—ALB—Metabolism—FASN—melanoma	7.36e-06	0.000101	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	7.27e-06	9.98e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A5—melanoma	7.24e-06	9.95e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—melanoma	7.07e-06	9.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNAQ—melanoma	6.99e-06	9.61e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD44—melanoma	6.99e-06	9.61e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—melanoma	6.91e-06	9.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.85e-06	9.41e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.78e-06	9.32e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—melanoma	6.78e-06	9.31e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1B1—melanoma	6.7e-06	9.21e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—melanoma	6.03e-06	8.28e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—melanoma	5.96e-06	8.19e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.92e-06	8.13e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—melanoma	5.87e-06	8.06e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NRAS—melanoma	5.8e-06	7.96e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—melanoma	5.78e-06	7.94e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK3—melanoma	5.55e-06	7.63e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—melanoma	5.54e-06	7.61e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—melanoma	5.52e-06	7.58e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK1—melanoma	5.28e-06	7.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PRKCA—melanoma	5.08e-06	6.98e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ERCC2—melanoma	5.04e-06	6.92e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—melanoma	4.99e-06	6.85e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—melanoma	4.87e-06	6.69e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—melanoma	4.59e-06	6.3e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—melanoma	4.44e-06	6.09e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—melanoma	4.24e-06	5.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.17e-06	5.73e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—melanoma	3.98e-06	5.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—melanoma	3.84e-06	5.28e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—melanoma	3.75e-06	5.14e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—melanoma	3.5e-06	4.81e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—melanoma	3.05e-06	4.19e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—melanoma	3.02e-06	4.15e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—melanoma	2.64e-06	3.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—melanoma	1.86e-06	2.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—melanoma	1.52e-06	2.09e-05	CbGpPWpGaD
